QR kód

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

Celý popis

Uloženo v:
Hlavní autoři: Raphael Mohr, Fabian Jost-Brinkmann, Burcin Özdirik, Joeri Lambrecht, Linda Hammerich, Sven H. Loosen, Tom Luedde, Münevver Demir, Frank Tacke, Christoph Roderburg
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021-03-01
Edice:Frontiers in Immunology
Témata:
hepatocellular carcinoma
immunotherapy
checkpoint inhibitor treatment
clinical trials
liver cirrhosis
On-line přístup:https://www.frontiersin.org/articles/10.3389/fimmu.2021.652172/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky